INNV vs. TVTX
INNV (InnovAge Holding Corp.) and TVTX (Travere Therapeutics, Inc.) are both stocks. Both are in the Healthcare sector — INNV in Medical Care Facilities, TVTX in Biotechnology. Over the past 5 years, INNV returned -16.14%/yr vs 29.95%/yr for TVTX. At a 0.19 correlation, their price movements are largely independent.
Performance
INNV vs. TVTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INNV achieves a 77.46% return, which is significantly higher than TVTX's 44.23% return.
INNV
- 1D
- 2.68%
- 1M
- 27.92%
- YTD
- 77.46%
- 6M
- 62.15%
- 1Y
- 136.76%
- 3Y*
- 7.61%
- 5Y*
- -16.14%
- 10Y*
- —
TVTX
- 1D
- -0.07%
- 1M
- 24.04%
- YTD
- 44.23%
- 6M
- 50.99%
- 1Y
- 285.12%
- 3Y*
- 50.58%
- 5Y*
- 29.95%
- 10Y*
- 11.96%
INNV vs. TVTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
INNV InnovAge Holding Corp. | 77.46% | 32.06% | -34.50% | -16.43% | 43.60% | -79.17% |
TVTX Travere Therapeutics, Inc. | 44.23% | 119.35% | 93.77% | -57.25% | -32.25% | 13.28% |
Correlation
The correlation between INNV and TVTX is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Mar 4, 2021 | 0.19 |
Fundamentals
INNV:
$1.25B
TVTX:
$5.06B
INNV:
-$0.16
TVTX:
-$0.49
INNV:
1.32
TVTX:
9.60
INNV:
5.37
TVTX:
51.28
INNV:
$945.90M
TVTX:
$536.20M
INNV:
$140.05M
TVTX:
$385.20M
INNV:
$5.26M
TVTX:
$11.15M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INNV vs. TVTX — Risk / Return Rank
INNV
TVTX
INNV vs. TVTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for InnovAge Holding Corp. (INNV) and Travere Therapeutics, Inc. (TVTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INNV | TVTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.37 | ||
| Sortino ratioReturn per unit of downside risk | -2.02 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.58 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | 4.14 | 8.58 | -4.43 |
| Martin ratioReturn relative to average drawdown | 8.13 | 19.84 | -11.71 |
Loading charts...
Drawdowns
INNV vs. TVTX - Drawdown Comparison
The maximum INNV drawdown since its inception was -89.92%, which is greater than TVTX's maximum drawdown of -85.43%. Use the drawdown chart below to compare losses from any high point for INNV and TVTX.
Loading charts...
Drawdown Indicators
| INNV | TVTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.92% | -85.43% | -4.49% |
Max Drawdown (1Y)Largest decline over 1 year | -33.21% | -33.49% | +0.28% |
Max Drawdown (3Y)Largest decline over 3 years | -65.42% | -69.51% | +4.09% |
Max Drawdown (5Y)Largest decline over 5 years | -88.24% | -83.12% | -5.12% |
Max Drawdown (10Y)Largest decline over 10 years | — | -83.64% | — |
Current DrawdownCurrent decline from peak | -64.63% | -0.07% | -64.56% |
Average DrawdownAverage peak-to-trough decline | -72.30% | -41.01% | -31.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.89% | 14.45% | +2.44% |
Volatility
INNV vs. TVTX - Volatility Comparison
InnovAge Holding Corp. (INNV) and Travere Therapeutics, Inc. (TVTX) have volatilities of 14.79% and 15.32%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INNV | TVTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.79% | 15.32% | -0.53% |
Volatility (6M)Calculated over the trailing 6-month period | 50.67% | 52.27% | -1.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 83.83% | 71.76% | +12.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 74.66% | 66.48% | +8.18% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 73.21% | 58.40% | +14.81% |
Dividends
INNV vs. TVTX - Dividend Comparison
Neither INNV nor TVTX has paid dividends to shareholders.
Financials
INNV vs. TVTX - Financials Comparison
This section allows you to compare key financial metrics between InnovAge Holding Corp. and Travere Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
INNV vs. TVTX - Profitability Comparison
INNV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, InnovAge Holding Corp. reported a gross profit of 0.00 and revenue of 251.94M. Therefore, the gross margin over that period was 0.0%.
TVTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 127.20M. Therefore, the gross margin over that period was 0.0%.
INNV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, InnovAge Holding Corp. reported an operating income of 0.00 and revenue of 251.94M, resulting in an operating margin of 0.0%.
TVTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported an operating income of -36.60M and revenue of 127.20M, resulting in an operating margin of -28.8%.
INNV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, InnovAge Holding Corp. reported a net income of -29.46M and revenue of 251.94M, resulting in a net margin of -11.7%.
TVTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported a net income of -37.10M and revenue of 127.20M, resulting in a net margin of -29.2%.
Frequently Asked Questions
INNV and TVTX have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TVTX has higher volatility (15.32%) compared to INNV (14.79%). In terms of maximum drawdown, INNV dropped -89.92% vs TVTX's -85.43%.
TVTX currently has the higher Sharpe Ratio (4.01 vs 1.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INNV and TVTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer